Gerda Redl
12Patents
7h-index
17Co-inventors
63Inventor score
Filing activity: Dec 14, 1993 → Jan 22, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6013620A | Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use | Chemistry; Metallurgy | 41 | Expired |
| US5891843A | Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use | Chemistry; Metallurgy | 40 | Expired |
| US8921279B2 | Display of binding agents | Physics | 13 | Active |
| US5639730A | Method of producing a virus-safe biological preparation | Emerging Cross-Sectional Technologies | 12 | Expired |
| US8859738B2 | Cytotoxic immunoglobulin | Chemistry; Metallurgy | 12 | Active |
| US5733885A | Method of producing a virus-safe biological preparation | Emerging Cross-Sectional Technologies | 8 | Expired |
| US9133274B2 | Method for engineering immunoglobulins | Chemistry; Metallurgy | 8 | Active |
| US9651559B2 | Display of binding agents | Physics | 7 | Active |
| US9255149B2 | Cytotoxic immunoglobulin | Chemistry; Metallurgy | 6 | Active |
| US8323650B2 | Method of treating lewis Y-expressing tumors | Chemistry; Metallurgy | 0 | Active |
| US10125197B2 | Cytotoxic immunoglobulin | Chemistry; Metallurgy | 0 | Active |
| US7759464B2 | N-glycosylated antibody | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.